VopF, a type III effector protein, has been identified as a contributory factor to the intestinal colonization of type III secretion system-positive, non-O1, non-O139 Vibrio cholerae strains. To gain more insight into the function of VopF, a yeast model was developed. Using this model, it was found that ectopic expression of VopF conferred toxicity in yeast.
INTRODUCTION
Vibrio cholerae, the aetiological agent of the diarrhoeal disease cholera, encompasses more than 200 serogroups, two of which (O1 and O139) are associated with cholera epidemics and pandemics. Studies on the pathogenesis of V. cholerae serogroup O1 and O139 have led to the identification of several critical virulence factors such as cholera toxin and the toxin co-regulated pilus. In addition, V. cholerae produces a major zinc-dependent metalloprotease known as haemagglutinin/protease. Strains belonging to the serogroups other than O1 and O139 are known collectively as the non-O1, non-O139 serogroup. Unlike their pathogenic counterparts O1 and O139, most non-O1, non-O139 strains are non-pathogenic and are found ubiquitously in the aquatic environment. Nevertheless, some members of this serogroup are capable of causing sporadic cases of moderate to severe gastroenteritis and extraintestinal infections in humans, despite the fact that the genes encoding toxin coregulated pilus and cholera toxin are absent, thus raising increasing concern in endemic areas. In contrast to O1 and O139 strains, non-O1, non-O139 strains employ a distinct virulence strategy that remains largely undefined. Recently, much work has been carried out in an effort to understand the biology in the context of pathogenesis and quorum sensing-mediated physiological events in these strains of V. cholerae (Chen et al., 2007; Dziejman et al., 2005; Joelsson et al., 2006; Raychaudhuri et al., 2006) . A comparative genomic microarray analysis has suggested that these strains are quite divergent from O1 and O139 strains. Moreover, sequence data mining has also revealed that the genes encoding the type III secretion system (T3SS) in these strains are related to the T3SS 2 gene cluster of Vibrio parahaemolyticus (Dziejman et al., 2005) . As non-O1, non-O139 strains are, by and large, devoid of cholera toxin and toxin co-regulated pilus, it is therefore conceivable that the T3SS could contribute towards the pathogenesis of these strains. In a continuing effort, Mekalanos and co-workers have characterized a T3SS effector molecule, VopF (NT01VC2350, WH2 motif domain protein), which has been posited to play a key role in enhancing the intestinal colonization of non-O1, non-O139 strains (Tam et al., 2007) . Functionally, VopF belongs to the group of bacterial virulence factors that interfere with actin homeostasis. It is a protein of 530 aa, containing one formin homology 1 (FH1)-like domain and three WASP homology 2 (WH2) domains. A proline-rich motif bridges the second and third WH2 domains. The possible way in which VopF may promote intestinal colonization could either be by introducing a specific localized cytotoxic effect on intestinal epithelial cells or by altering the actin cytoskeleton of neutrophils to evade the innate immune response (Tam et al., 2007) .
Recent work has witnessed the introduction and development of Saccharomyces cerevisiae as a model genetic system to identify and characterize the function of virulence factors, especially those translocated by T3SSs (Valdivia, 2004) . Indeed, the expression of various virulence determinants from pathogenic bacteria such as Yersinia (Nejedlik et al., 2004; Von Pawel-Rammingen et al., 2000; Yoon et al., 2003) , Salmonella (Lesser & Miller, 2001; Rodríguez-Pachó n et al., 2002) , Pseudomonas aeruginosa (Rabin & Hauser, 2003; Sato et al., 2003) , V. parahaemolyticus (Trosky et al., 2004) , Legionella (Shohdy et al., 2005) , enteropathogenic Escherichia coli (Rodríguez-Escudero et al., 2005) , Campylobacter jejuni (Hassane et al., 2001) and Chlamydia pneumoniae (Huang et al., 2008) (Arnoldo et al., 2008; Huang et al., 2008) .
In this study, we wanted to evaluate the suitability of budding yeast as a model system to study the function of VopF. Here, we report the effect of systemic heterologous expression of VopF from non-O1, non-O139 V. cholerae serogroup O34 in S. cerevisiae. Upon expression, VopF conferred growth inhibition coupled with cell-cycle arrest at the G 2 /M transition in the budding yeast.
METHODS

Organisms.
A clinical isolate of non-O1, non-O139 V. cholerae strain SC110 serogroup 034 served as a source for the type III effector molecule VopF. E. coli NovaBlue strain was used for general cloning purposes. Both E. coli and V. cholerae were propagated at 37 uC in liquid with agitation in Luria broth or on solid 1.5 % L-agar unless stated otherwise. S. cerevisiae strain W303-1A (MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-100 GAL SUC2) was used in this study (Table 1) .
Construction of strains. The vopF gene was amplified from the genomic DNA of V. cholerae strain SC110 using the primers KasI VopF and XbaI VopF ( Table 2 ). The fidelity of the amplified product was verified by sequencing (GenBank accession no. EU862280). The product was further cloned into the KasI/XbaI sites of pYES260 under the control of the GAL1 promoter. Positive clones were further confirmed by sequencing and maintained in E. coli strain NovaBlue cells. The recombinant construct, designated pSRT, was subsequently transformed into S. cerevisiae strain W303-1A (his3-11 leu2-1 ade2-1 ura3-52 trp1-1). The resultant strain was designated W303-SRT (GAL1-VopF). This study
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VopF contains one FH1 and three WH2 domains, which are required for actin nucleation and polymerization activity (Tam et al., 2007) . These domains were deleted individually, as well as in combination, using the GeneTailor site-directed mutagenesis system (Invitrogen). The primers were designed according to the instructions provided and are listed in Table 2 . The mutant constructs were sequenced in their entirety to confirm the clone and the desired mutations at the corresponding positions. The recombinant constructs, designated pSRN1, pSRN2, pSRN3, pRC, pSRC and pSWF, were subsequently transformed into S. cerevisiae strain W303-1A to create S. cerevisiae
Growth assay. The yeast strain W303-1A was grown in YPD [1 % (w/v) yeast extract, 2 % (w/v) peptone, 2 % (w/v) glucose) broth or agar. To evaluate the functionality of VopF, a galactose induction experiment was carried out essentially as described previously (Rodríguez-Escudero et al., 2005) . Briefly, the transformed yeast strains W303-SR (harbouring pYES260 alone), W303-SRT, W303-SRN1, W303-SRN2, W303-SRN3, W303-RC, W303-SRC and W303-SWF were grown in synthetic selective medium (SC) containing 0.17 % (w/v) yeast nitrogen base without amino acids, 0.5 % (w/v) ammonium sulphate and 2 % (w/v) glucose, and supplemented with appropriate amino acids and nucleic acid bases. SC Gal and SC Raf were SC media containing 2 % (w/v) galactose or raffinose, respectively, instead of glucose. For induction experiments, W303-SR, W303-SRT, W303-SRN1, W303-SRN2, W303-SRN3, W303-RC, W303-SRC and W303-SWF were grown in SC Raf medium at 30 uC to exponential phase, followed by addition of galactose to a final concentration of 2 % (w/v) and further growth for 6 h. The effect of the expression of VopF and its various derivatives on the growth of S. cerevisiae was examined by spotting equal numbers of cells onto SC and SC Gal plates lacking the corresponding auxotrophic markers to maintain the plasmids. Growth was monitored after 2-3 days at 30 uC and photographed.
Measurement of yeast DNA content. It has been documented that ectopic expression of several bacterial virulence factors causes growth inhibition in yeast by cell-cycle arrest (Hassane et al., 2001; Huang et al., 2008; Rodríguez-Escudero et al., 2005) . In order to gain further insight into how VopF causes growth inhibition, the yeast DNA content was measured by propidium iodide (PI; Sigma) staining, essentially as described previously (Hassane et al., 2001) . To achieve this, W303-SR, W303-SRT and W303-SWF were sampled at 10 h after induction, followed by fixing and treatment with PI. At least 10 000 events were assessed by fluorescence-activated cell sorting (FACS) for PI fluorescence intensity using a FACScan flow cytometer (Becton Dickinson).
Microscopy. As VopF perturbs the actin dynamics and cell morphology of human epithelial HEp-2 cells (Tam et al., 2007) , we wanted to examine the integrity of the actin network of yeast expressing VopF. To this end, recombinant yeast cells were harvested after galactose induction at stipulated time points and fixed in 3.7 % formaldehyde for 1 h at 4 uC as described elsewhere (Nejedlik et al., 2004) . After washing, cells were resuspended in PBS supplemented with FITC-labelled phalloidin (Sigma) to visualize the actin and examined under a confocal microscope (Zeiss). For the localization study, VopF was C-terminally tagged with mCherry by an overlapping PCR method. Briefly, mCherry and vopF were amplified from the pmCherry-C1 plasmid (Clontech) and pSRT (Table 1) Table 2 ). The products were purified and overlapping PCR was performed with primer pair BamHI Fwd VopF/ XbaI mCherry V Rev. The final product was cloned into the BamHI/ XbaI sites of the pEG(KG) vector. The resultant recombinant plasmid, pSRT-mCherry, was transformed into W303-1A to create W303-SRTmCherry. In a similar manner, W303-SRTmCherry was harvested after galactose induction, followed by fixing and staining with FITClabelled phalloidin, and visualized under a confocal microscope.
RESULTS AND DISCUSSION
Expression of VopF in S. cerevisiae affects cell growth
The budding yeast S. cerevisiae has been exploited as a model genetic system to elaborate the function of virulence factors, especially those translocated by T3SSs (Valdivia, 2004) . In the present work, we wanted to evaluate the suitability of S. cerevisiae as a genetic system to study the function of VopF. To investigate whether VopF possesses toxic activity, we expressed this protein ectopically under the control of the GAL1 promoter in an S. cerevisiae strain (Fig. 1a) .
VopF-induced toxicity depends on the FH1 and WH2 domains
It has been shown that VopF contains one FH1 domain and three WH2 domains, which are required for actin nucleation and polymerization activity (Tam et al., 2007) .
To ascertain whether actin polymerization activity of VopF is essential to exert growth inhibition in yeast, the respective domains were deleted individually, as well as in combination, and the resulting constructs were transformed into S. cerevisiae strain W303-1A to create W303-SRN1 (GAL1-VopFDWH2 dm2, dm3), W303-SRN2 (GAL1-VopFDWH2 dm1, dm3), W303-SRN3 (GAL1-VopFDWH2 dm1, dm2), W303-RC (GAL1-VopFDFH1), W303-SRC (GAL1-VopFD3WH2 dm1, dm2, dm3) and W303-SWF (GAL1-VopFD3WH2 dm1, dm2, dm3 DFH1).
These recombinant strains were further subjected to growth assays in galactose-containing medium. Our data clearly revealed that the extent of growth inhibition exerted by VopF was dependent on the actin-binding domains, whereby W303-SRT (GAL1-VopF) exhibited maximum inhibition, followed by W303-RC (GAL1-VopFDFH1) and W303-SRC (GAL1-VopFD3WH2) (Fig. 1a) . There was no inhibition of growth of W303-SWF (GAL1-VopFD3WH2DFH1) compared with the vector control, which clearly suggested that actin polymerization activity of VopF is required for growth inhibition in S. cerevisiae (Fig. 1a) . These data also suggested that the cumulative action of the three WH2 domains on the growth of budding yeast is stronger than that of the FH1 domain alone. To determine the contribution of individual WH2 domains, a series of VopF variant molecules were constructed by deleting double WH2 domains in wildtype VopF (Table 1) . Subsequently, these variant VopF constructs harbouring FH1 and any one of the three WH2 domains were transformed into the budding yeast to test their growth inhibitory capacity. Notably, the growth assay with recombinant strains transformed with VopF variants containing single WH2 domains, namely W303-SRN1, W303-SRN2 and W303-SRN3, revealed an intriguing result whereby W303-SRN3 exhibited less growth than W303-SRN1 and W303-SRN2, thus indicating that domain 3 exerts a stronger inhibitory effect than domains 1 and 2 (Fig. 1a) .
Expression of VopF results in an accumulation of G 2 -arrested cells
To understand whether VopF-induced growth inhibition was accompanied by a concomitant arrest of the cell cycle, a flow cytometric analysis was conducted to determine the DNA content of cells expressing GAL1-VopF and GAL1-VopFD3WH2DFH1 relative to the vector control. As shown in Fig. 2 , cells containing vector alone (W303-SR) as well as cells expressing mutant VopF (W303-SWF) showed a balanced proportion of G 1 and G 2 /M cells. In contrast, the strain expressing wild-type VopF (W303-SRT) exhibited an accumulation of G 2 /M cells, thus suggesting a specific cell-cycle arrest.
Expression of VopF alters actin distribution
As VopF has been demonstrated to induce actin-rich protrusion formation by interfering with actin dynamics in tissue culture cells (Tam et al., 2007) , we wanted to determine whether expression of VopF altered the distribution of actin in the budding yeast S. cerevisiae. In yeast cells in which wild-type VopF was expressed from the GAL1 promoter (W303-SRT), actin showed a diffuse pattern with no cortical patches or cables visible, which was in sharp contrast to the organized actin pattern with distinct cortical patches and cables seen in yeast cells transformed with vector alone (W303-SR) (Fig. 3) . These data indicated that the normal distribution of actin was affected by wild-type VopF.
Localization of VopF in yeast cells
To determine its localization, VopF was C-terminally tagged with mCherry. The resulting construct, pSRTmCherry, was transformed to generate the recombinant yeast strain W303-SRTmCherry (GAL1-VopFmCherry). Previously, it has been documented that fusion of a fluorescent tag at the N-or C-terminus sometimes results in a non-functional derivative (Sturgill et al., 2008) . To evaluate the functionality of the VopF-mCherry fusion construct, the recombinant strain W303-SRTmCherry was subjected to a growth assay in a similar manner to that adopted for untagged strains such as W303-SRT. Upon induction, VopF-mCherry conferred growth inhibition in W303-SRTmCherry (Fig. 4a) , thus indicating that the fusion of mCherry at the C terminus of VopF did not alter its activity. Next, we examined the cellular localization of VopF-mCherry. To achieve this, W303-SRTmCherry cells were harvested at 1 h time points following the addition of galactose and stained with FITC-labelled phalloidin to visualize actin. Our results revealed that mCherry-tagged VopF was dispersed throughout the cytoplasm and was also localized at the cell periphery (Fig. 4b ). Further staining with FITC-labelled phalloidin suggested colocalization of VopF with cellular actin.
In conclusion, expression of VopF caused growth inhibition by arresting the cell cycle at the G 2 /M phase in the budding yeast S. cerevisiae. Furthermore, we demonstrated that the VopF-mediated inhibitory growth phenomenon in yeast is likely to be dependent on the domains that are required for actin nucleation and polymerization activity. Interestingly, our domain-deletion analysis suggested that the VopF variant comprising the FH1 domain in combination with only domain 3 of WH2, and not domains 1 and 2, was more efficient at restricting the growth of budding yeast. One possible reason could be the Toxicity of V. cholerae VopF in a yeast model sequence diversity within each WH2 domain of VopF. The critical amino acids that are important for actin binding to WH2 domains have been determined previously (Quinlan et al., 2005) . Based on this knowledge, a consensus sequence has been generated (Liverman et al., 2007) . CLUSTAL W alignment of all three WH2 domains of VopF and the consensus sequence identified maximum homology with domain 3, rather than domains 1 and 2 (Liverman et al., 2007; Fig. 1b) . In addition to conserved residues, there is a varying number of non-conserved residues in each domain.
As there remains a diversity of amino acid sequence in each WH2 domain, it would be interesting to ascertain the contribution of these amino acids in the functioning of VopF. This warrants further investigation.
Recent studies have produced a rich harvest of data that reveal how various pathogens have evolved with a myriad of virulence determinants containing eukaryotic actinbinding domains that in turn help them to usurp the host actin cytoskeleton machinery. Harnessing actin cytoskeleton dynamics promotes adherence, invasion and intracellular locomotion of pathogens. Virulence factors such as VopL from V. parahaemolyticus (Liverman et al., 2007) , TARP from Chlamydia (Jewett et al., 2006) , SipC from Salmonella (Hayward & Koronakis, 2002) , Map from pathogenic E. coli (Dean et al., 2005) It is now known that actin perturbation can trigger a morphogenesis checkpoint response in budding yeast (McMillan et al., 1998) . It seems likely that the growth inhibition in VopF-expressing yeast cells may be mediated through this checkpoint. In light of the present work, we surmise that this yeast model will be useful for analysis of VopF. This model will be a valuable tool to expedite the identification of the intracellular target of VopF and also useful to screen small-molecule inhibitors against this effector molecule. Additional studies are necessary to address these issues. C-terminally mCherry-tagged vopF was inducibly expressed in selective medium containing 2 % galactose from the GAL1 promoter in S. cerevisiae cells. Cells were harvested after 1 h of induction and fixed with 3.7 % formaldehyde for 2 h. FITC-labelled phalloidin was added to the cultures to visualize actin. The results showed that VopF colocalized with the actin patches (arrows), as well as being present in a diffuse fashion. RFP, Red fluorescent protein.
